[Beta-pyridyl-carbinol in the treatment of hyperlipoproteinemia].
D000787:Angina Pectoris / Q000517:prevention & control; D003692:Delayed-Action Preparations; D004341:Drug Evaluation; D004361:Drug Tolerance; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy; D006949:Hyperlipidemias / Q000188:drug therapy*; D007383:Intermittent Claudication / Q000188:drug therapy; D009536:Niacinamide / Q000096:biosynthesis; D009540:Nicotinyl Alcohol / Q000378:metabolism / Q000627:therapeutic use*; D011725:Pyridines / Q000627:therapeutic use*
D003692:Delayed-Action Preparations; D011725:Pyridines; D009536:Niacinamide; D009540:Nicotinyl Alcohol
Beta-Pyridyl-carbinol in der Therapie der Hyperlipoproteinämie.